Skip to main content
. 2018 Oct 15;5:2054358118804838. doi: 10.1177/2054358118804838

Figure 3.

Figure 3.

Adjusted hazard ratios with 95% confidence intervals for the association between ACE-I/ARB use and all-cause mortality in Southern Alberta cohort hospitalized with heart failure, stratified by discharge eGFR, and for the overall cohort.

Note. ACE-I = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; eGFR = estimated glomerular filtration rate.